Chen, J., Liu, J.-S., Liu, J.-Y., She, L., Zou, T., Yang, F., Li, X.-P., Wang, Z., Liu, Z.

Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors

11 de July de 2024 by Chen, J., Liu, J.-S., Liu, J.-Y., She, L., Zou, T., Yang, F., Li, X.-P., Wang, Z., Liu, Z.

Background
Metabolomics has the characteristics of terminal effects and reflects the physiological state of biological diseases more directly. Several current biomarkers of multiple omics were revealed to be associated with immune-related adverse even…